Back to results
US 2006/0234313 A1Published application
Modulation of angiogenesis through targeting of arginyl transferase (ATE1)
AssigneeCalifornia Institute of Technology
InventorsYong Kwon, Anna Kashina, Aleander Varshavsky
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for modulating angiogenesis in a subject. The methods of modulating angiogenesis in a subject include administering to the subject a modulator of N-terminal arginylation activity. The invention also provides a method of identifying such a modulator and a method of in vitro screening for modulators of N-terminal arginylation activity. Additionally, the invention provides a method of treating an angiogenesis-related disorder.
Claims25
A method of screening for a modulator of N-terminal arginylation activity, comprising:
- a) contacting at least one potential modulator of N-terminal arginylation activity with a first cell that expresses a first reporter protein, wherein the first reporter protein has an N-terminal aspartic acid, glutamic acid or cysteine residue and a half-life that is affected by arginylation of the N-terminal residue;
- b) measuring the level of the reporter protein expressed by the first cell and the level of reporter protein expressed by a control cell not exposed to the at least one potential modulator;
- c) comparing the level of the reporter protein expressed by the first cell with the level of reporter protein expressed by the control cell, wherein a difference in levels indicates of modulation of N-terminal arginylation activity, thereby screening for a modulator of N-terminal arginylation activity.
Dependencies are inferred from the claim text.